Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-16-121929

Director bought 45,000 shares at an average $1.53 ($68,700)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Sigal Charles Elliott Director 2016-05-16 Purchase +15,000 $1.50 $22,500 269,100 I
Sigal Charles Elliott Director 2016-05-17 Purchase +15,000 $1.53 $22,950 284,100 I
Sigal Charles Elliott Director 2016-05-18 Purchase +15,000 $1.55 $23,250 299,100 I
Open-market purchases · 45,000 sh · avg $1.53 · $68,700
Loading xslF345X03/a4.xml…